Abstract
AbstractTwo new approaches, Magnetic Drug Targeting (MDT) and Magnetic Hyperthermia, are being investigated in order to reduce side effects generated by common ways of cancer treatment. MDT and MHT are based on the use of magnetic nanoparticles: for MDT the nanoparticles are used as drug carriers and for MHT the nanoparticles are used to induce local heat transfer within the tumour. The success of these therapeutic approaches depends among other things on the correct distribution of the magnetic nanoparticles within the tumour tissue. Computed tomography analysis has been performed on tumour tissue after MDT in order to examine this distribution. The measurements have been performed in two different laboratories, one based on a synchrotron radiation, and another one on a cone X–ray source. First results show that the drug carriers are contained in the vessel system of the tumour as well as concentrated in the surrounding area of the veins. (© 2008 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
